Comparison Study of BD Onclarity HPV With digene HC2 High-Risk HPV DNA Test and Roche Cobas 4800 HPV for Detecting High-Risk Human Papillomavirus in Japan.

Conclusion: The results showed that the clinical performance of Onclarity was equivalent to HC2 and Cobas.
PMID: 30260388 [PubMed - as supplied by publisher]

Source: American Journal of Clinical Pathology - September 26, 2018 Category: Pathology Authors: Nakamura M, Nakade K, Orisaka S, Iwadare J, Mizumoto Y, Fujiwara H Tags: Am J Clin Pathol Source Type: research